Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/phcogcommn/phcogcommn.org/sites/all/modules/biblio/includes/biblio_theme.inc).

Editorial

Jan
30
2018
By tahmed

groupview

Abstract
Pharmacognosy Communications,2018,8,1,1.
DOI:10.5530/pc.2018.1.1
Published:January-2018
Type:Editorial

Editorial

I.E. Cock1,2* (Editor-In-Chief)

1Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

2School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

Abstract:

Dear readers and authors,

Welcome to a new and hopefully fruitful year. I am pleased to bring you the first issue of Pharmacognosy Communications for 2018: volume 8, issue 1. In this issue we present 8 new original research reports examining the pharmacognosy of several important medicinal plants including reports on: a review of both the positive actions and side effects of statins; the anticancer properties of Uncaria tomentosa Willd. DC. extracts against Caco2 and HeLa cancer cell lines; a comparison of the anticholinesterase, antioxidant and cytotoxic activities of Allium cepa and Ocimum basilicum and therefore their potential in drug development for the treatment of Alzheimers Disease; the hepato-protective effects of Monodora myristica (Gaertn.), Chromolaena odorata (Linn), Buccholzia coriacea (Engl.) and Sphenostylis stenocarpa (Hochst ex A. Rich) following carbon tetrachloride exposure; the effects of herbal combinations on serum lactate dehydrogenase activity and organ weight in a diabetes mellitus model system; a pharmacognostic comparison of the leaves of Citrus sinensis var. jaffa and Citrus paradisi var. redblush; the antioxidant, antihemolytic and anti-inflammatory activities of Santolina chamaecyparissus extracts; the antioxidant properties and xanthine oxidase inhibitory activity of the Algerian medicinal plant Paronychia argentea L. Read more . . . 

Keywords:Editorial

View:

Tags: 

Cite This Article

Vancouver Style :: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(1):1.  (496.3 KB)
MLA Style: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(1):1.  (496.3 KB)
CSE Style: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(1):1.  (496.3 KB)
APA Style: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(1):1.  (496.3 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

 

ISSN :2249-0159 (Print) ; 2249-0167 (Online)

Frequency : Quarterly Rapid at a time publication (4 issues/year)

 

 

 

 

Pharmacognosy Communications -an official publication of Phcog.Net and the journals and its contents owned by Phcog.Net are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with journals@phcog.net

Copyright 2015-16 Phcog.Net | Publishing partner: EManuscript Services